A meta-analysis of six randomized, double-blind, placebo-controlled trials in mild-to-moderate Alzheimer's disease in which patients received 30 mL/day of Cerebrolysin (or placebo) by IV for at least four weeks reported an overall beneficial effect on cognitive function and on global clinical change, with a favorable benefit-risk profile (Gauthier et al
Pharma 31 1356 January 10, 2024 Has Anyone Here Tried BPC 157 or TB500
After this interaction, glutathione is transformed from its reduced form to its oxidized one
External Research Resources For independent literature discovery, researchers can review a PubMed literature search for GHK-Cu and compare findings with their own protocol, controls, and institutional review process
Keep them in a secure place away from children and pets
BPC -157 is a 15 amino acid partial sequence of Body protection compound that was discovered and isolated in gastric juice